The chemicals raged uselessly while the fungus remained alive
Each breath carries invisible spores that most bodies quietly neutralize, yet for the immunocompromised, that same invisible encounter can become fatal. Researchers at the University of East Anglia have now identified a single protein — RAB5c — that determines whether the immune system's assault on Aspergillus fumigatus actually lands or merely rages in place. The discovery reframes a long-standing medical puzzle: sometimes the body is not failing to fight, but failing to coordinate the fight it has already begun.
- Tens of thousands die each year from a fungal infection that healthy lungs repel effortlessly, yet medicine has long lacked the tools to protect those most at risk.
- Researchers found that immune cells without RAB5c actually overproduce toxic molecules — yet the fungus survives, exposing a hidden gap between effort and effectiveness.
- RAB5c acts as a molecular traffic controller, assembling the acid pump that allows lethal chemicals to reach their target at precisely the right moment inside the cell.
- Mouse models confirmed the stakes: animals lacking the RAB5c pathway carried far heavier fungal loads, suffered greater tissue damage, and mounted inflammation that harmed without healing.
- The pathway implicated touches viral, bacterial, cancer, and autoimmune responses alike, suggesting that enhancing immune coordination — rather than attacking pathogens directly — may be the more powerful therapeutic frontier.
Every day, most people inhale spores from Aspergillus fumigatus without consequence. For those whose immune systems are weakened — by cancer treatment, organ transplants, or lung disease — those same spores can invade, spread, and kill. Tens of thousands die from this infection annually. Now a research team spanning the University of East Anglia, the Babraham Institute, and the Universidade de Sao Paulo has identified the protein that determines whether the immune system can actually finish what it starts.
The protein is called RAB5c. When a macrophage engulfs a fungal spore, it normally seals it inside a compartment that acidifies, fills with toxic molecules, and triggers a specialized killing sequence. RAB5c functions as the traffic controller that makes this sequence possible — ensuring the right enzymes arrive at the right moment and that a critical acid pump, the V-ATPase, is properly assembled. Without it, the operation stalls in a paradoxical way: macrophages actually produce more toxic oxygen molecules than usual, yet the fungus survives because those molecules are never properly deployed.
The team confirmed the finding in mice. Animals lacking the RAB5c pathway carried significantly higher fungal loads, sustained more tissue damage, and mounted inflammatory responses that consumed energy without clearing infection. Mice with the pathway intact cleared the fungus far more effectively. The gap was not subtle.
What makes the discovery broadly significant is that the same pathway governs how the body responds to viruses, bacteria, and even cancer cells, and how it regulates autoimmune activity. Future therapies built on this insight might not target the fungus at all — they might instead fine-tune the patient's own immune machinery to coordinate its existing force more precisely. The lesson embedded in RAB5c is that immune failure is sometimes not a shortage of weapons, but a failure of direction.
Every day, most of us breathe in spores from a fungus called Aspergillus fumigatus without consequence. For people whose immune systems are compromised—those undergoing cancer treatment, recovering from organ transplants, or living with lung disease—those same spores can invade the lungs, spread through the body, and kill. Tens of thousands die from this infection each year worldwide. Now researchers at the University of East Anglia, working with collaborators at the Babraham Institute and Universidade de Sao Paulo in Brazil, have identified a single protein that acts as the master switch determining whether the immune system can actually finish the job of destroying the fungus, even when it appears to be fighting at full strength.
The protein is called RAB5c, and its role is surprisingly specific. When a white blood cell called a macrophage encounters a fungal spore, it engulfs it into a sealed compartment. Under normal circumstances, that compartment acidifies, fills with toxic molecules, and triggers a specialized killing process known as LC3-associated phagocytosis. But the researchers discovered that none of this works without RAB5c. The protein functions like a traffic controller inside the cell, ensuring that lethal molecules and enzymes arrive at exactly the right moment. Without it, the entire operation stalls.
To understand this, the team watched immune cells under microscopes as they consumed fungal particles. They then systematically switched off different genes to identify which ones were essential for killing the fungus. When they removed RAB5c, something counterintuitive happened. The macrophages actually produced more toxic oxygen molecules than normal—one of the immune system's most powerful weapons. Yet the fungus survived anyway. The toxic molecules were being generated but not properly deployed. RAB5c, it turned out, plays a crucial role in assembling a microscopic structure called the V-ATPase, an acid pump that allows those oxygen radicals to trigger the final killing steps. Without the pump, the chemicals raged uselessly while the fungus remained alive.
The researchers tested this discovery in mice infected with Aspergillus. Animals unable to use the RAB5c pathway had far higher fungal loads in their lungs, more tissue damage, and stronger inflammatory responses. Mice with a fully functioning pathway cleared the infection far more effectively. The difference was stark and measurable. This wasn't a laboratory abstraction—it was the difference between an immune system that could protect and one that could not, despite appearing to mount an aggressive response.
The implications extend beyond fungal disease. The same immune pathway is involved in how the body kills viruses and bacteria, controls inflammation, mounts cancer immunity, and regulates autoimmune disorders. Rather than developing drugs that attack the fungus directly—a notoriously difficult task given how resistant these infections are to treatment—future therapies might instead enhance the patient's own immune machinery, fine-tuning it to work more efficiently. The discovery suggests that sometimes the immune system's failure is not a matter of insufficient force but of misdirected effort. Understanding the mechanism that coordinates that effort opens a new avenue for treatment.
Citações Notáveis
RAB5c acts like a traffic controller inside immune cells. It ensures that lethal molecules and enzymes reach the phagosome at exactly the right moment. Without it, the clean-up operation grinds to a halt.— Prof Tom Wileman, University of East Anglia
Our results help explain why some immune responses fail, despite appearing aggressive, and why overstimulation doesn't always mean better protection.— Prof Tom Wileman
A Conversa do Hearth Outra perspectiva sobre a história
So the immune cells are actually fighting, but they're losing anyway. How does that happen?
They're producing the right weapons—toxic molecules that should kill the fungus. But without RAB5c, those weapons aren't being delivered to the right place at the right time. It's like having ammunition but no way to load the gun.
And RAB5c is what loads the gun?
More precisely, it assembles the structure that allows the toxic molecules to work. It's a traffic controller making sure everything arrives in the right order. Without it, the molecules are just floating around uselessly.
Why does this matter for treatment? Can't we just give people more of this protein?
That's one possibility, but the real insight is broader. It means we've been thinking about fungal infections wrong. We've been trying to kill the fungus directly. But if we can enhance the immune system's own machinery—make it more efficient at what it's already trying to do—we might have better results with fewer side effects.
Does this apply to other infections too?
Yes. The same pathway is involved in fighting viruses, bacteria, and even cancer. Understanding how to optimize it could have implications across multiple diseases.